{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group ( POG ) P9605 ( standard risk ) and P9201 ( lesser risk ) acute lymphoblastic leukemia protocols ( ACCL0131 ) : a methotrexate consequence ?\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Acute lymphoblastic leukemia |\n| Neurocognitive |\n| Neuroradiologic |\n| Central nervous system late effects |\n\nNote: \"Neurocognitive\" and \"Neuroradiologic\" are not diseases in the classical sense, but they are mentioned in the context of disease late effects, so they are included in the table."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Here's the updated table with only the entities that clearly refer to diseases:\n\n| Disease |\n| --- |\n| Acute lymphoblastic leukemia |\n| Central nervous system late effects |\n\nThe entities \"Neurocognitive\" and \"Neuroradiologic\" are not included in the table as they do not clearly refer to diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group ( POG ) P9605 ( standard risk ) and P9201 ( lesser risk ) acute lymphoblastic leukemia protocols ( ACCL0131 ) : a methotrexate consequence ?\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Methotrexate |\n\nThe paragraph mentions \"methotrexate\" as a chemical entity."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with the valid chemical entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Methotrexate |\n\nThe paragraph only mentions \"Methotrexate\" as a chemical entity."}
  ]
}